About Novaxia
For more than twenty years…
Founded in 1996, Novaxia Laboratory is a Contract Research Organisation (CRO) specialized in histology / pathology, now part of ERBC Group (European Research Biology Center).
Novaxia accompanies you in the development of your projects by implementing technical and scientific expertise in order to bring solutions as close as possible to your needs.
In addition to responding to the specific needs of each customer, our expertise also allows us to offer new proposals. For this reason, with a concern for efficiency, we want to build a partnership of trust in the long term with our customers.
Our customers’ satisfaction and that of our team is our primary commitment.
Our team : EXPERTISE. ADVICE. COMMUNICATION.
At Novaxia, we help you to shape your complex and global studies from the very beginning. Our passion is to provide you with the tools and the precise knowledge that will allow you to successfully complete your projects.
Our team is experienced, responsive, and qualified; our technical staff undergoes rigorous in-house training complemented by a continuous improvement program; as a result, we are able to build lasting working relationships based on mutual trust and integrity.
Our experts are available to travel to provide support to your teams.
Our Board-certified veterinary Pathologist
Catherine Botteron
DVM, PhD, dECVP
Joined Novaxia in January 2023
30+ years experience in veterinary pathology, including activities in research, diagnostic, toxicologic pathology, neuropathology and medical device pathology
Celine Thuilliez
DVM, DESV-AP, dECVP, dABT
Joined Novaxia in January 2023
15+ years experience in veterinary pathology and toxicology in pharma company and CRO, including activities in research, diagnostic, toxicologic and investigative pathology, tissue biomarkers and translational medicine
Cécile Sobry
DVM, MSc, DESV-AP, dACVP
Joined Novaxia in January 2023
20+ years experience in toxicologic pathology in GLP environment (pharma and CRO). Key competencies: NHP pathology, carcinogenicity studies, toxicologic pathology of therapeutic nucleic acids, biotherapeutics and immunomodulatory drugs